Vimarsana
Biggest News Aggregation in the World

Page 18 - Study Author News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Author. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Author Today - Breaking & Trending Today

Bystander defibrillation improves 30-day survival even with short ambulance response times - Vimarsana News

Bystander defibrillation improves 30-day survival even with short ambulance response times

Using a defibrillator for a cardiac arrest victim improves 30-day survival even with ambulance response times as short as two minutes, according to research presented at ESC Congress 2023.

Sedentary lifestyle in young people may harm heart health - Vimarsana News

Sedentary lifestyle in young people may harm heart health

Hours of inactivity during childhood could be setting the stage for heart attacks and strokes later in life, according to research presented at ESC Congress 2023.

Recognizing and acting on heart attack symptoms linked to faster treatment, better outcomes - Vimarsana News

Recognizing and acting on heart attack symptoms linked to faster treatment, better outcomes

Recognizing and acting on heart attack symptoms is linked with faster life-saving treatment, according to research presented at ESC Congress 2023.

Keeping fit may help prevent atrial fibrillation and stroke - Vimarsana News

Keeping fit may help prevent atrial fibrillation and stroke

A study in more than 15,000 people has found that physical fitness is linked with a lower likelihood of developing atrial fibrillation and stroke. The research is presented at ESC Congress 2023.

Aspirin adherence after heart attack linked to lower risk of recurrent heart attack, stroke, death - Vimarsana News

Aspirin adherence after heart attack linked to lower risk of recurrent heart attack, stroke, death

Heart attack patients who do not take daily aspirin have an elevated likelihood of recurrent myocardial infarction, stroke or death compared with those who consistently take the drug, according to research presented at ESC Congress 2023.